Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Sunday, September 27

3:00 PM - 4:00 PM ET

Advances in Radiation Response and Microenvironment
Speaker: Connolly, Eileen, MD, PhD - New York Presbyterian Hospital Columbia Campus, New York, NY
3:00 PM - 4:00 PM ET

Escalate, De-escalate, or Substitute? Trials Shaping Prostate Cancer Care
Speaker: Roy, Soumyajit, MBBS, MSc. - University Hospitals Seidman Cancer Center, Cleveland, OH
3:00 PM - 4:00 PM ET

Escalate, De-escalate, or Substitute? Trials Shaping Prostate Cancer Care
Speaker: Choi, Seungtaek, MD - MD Anderson Cancer Center - Proton Therapy Center, Houston, TX
3:00 PM - 3:05 PM ET

Introduction
Speaker: Andrews, Janna, MD, FASTRO - North Shore-Long Island Jewish Health System, New Hyde Park, NY
3:00 PM - 3:05 PM ET

Introduction
Speaker: Liu, Kevin, MD, DPhil - Brigham and Womens Hospital, Boston, MA
3:00 PM - 4:00 PM ET

Medical Education/Professional Development Oral Abstracts
Speaker: Ni, Lisa, MD - University of Washington, Seattle, WA
3:00 PM - 4:00 PM ET

Medical Education/Professional Development Oral Abstracts
Speaker: Janowski, Einsley-Marie, MD, PhD - University of Virginia, Charlottesville, VA
3:00 PM - 4:00 PM ET

Multidimensional Toxicity in Breast Cancer Radiotherapy: Integrating Clinical, Patient-Reported, and Biological Outcomes
Speaker: Corbin, Kimberly, MD - Mayo Clinic, Rochester, MN
3:00 PM - 4:00 PM ET

Multidimensional Toxicity in Breast Cancer Radiotherapy: Integrating Clinical, Patient-Reported, and Biological Outcomes
Speaker: Andrews, Janna, MD, FASTRO - North Shore-Long Island Jewish Health System, New Hyde Park, NY
3:00 PM - 4:00 PM ET

Technologically Driven strategies in HPVrelated OPSCC
Speaker: Razavian, Niema, MD - Moffitt Cancer Center, Tampa, FL
3:00 PM - 4:00 PM ET

Technologically Driven strategies in HPVrelated OPSCC
Speaker: Spencer, Sharon, MD - University of Alabama at Birmingham, Birmingham, AL
3:05 PM - 3:10 PM ET

1000 - Safety of Postoperative Concurrent Capecitabine and Intensity-Modulated Radiotherapy in Triple-Negative Breast Cancer: Results from a Phase II Prospective Study
Speaker: Li, Jiaxuan, MD - Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing